Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial. [PDF]
Afzali A +17 more
europepmc +1 more source
Achieving Minimal-to-No Pain in Women with Endometriosis Treated with Relugolix Combination Therapy: SPIRIT Extension Trial. [PDF]
Lukes AS +8 more
europepmc +1 more source
Further data to address the Alzheimer's coverage with evidence development questions. [PDF]
Boustani M +9 more
europepmc +1 more source
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results. [PDF]
Pittock SJ +14 more
europepmc +1 more source
Biomedical sensing analyzer (BSA) for mobile-health (mHealth)-LTE
The rapid expansion of mobile-based systems, the capabilities of smartphone devices, as well as the radio access and cellular network technologies are the wind beneath the wing of mobile health (mHealth).
Sasan Adibi (11629147)
core
Reply: "Entering a new GALAXI: The importance of long-term data in Crohn's disease clinical trials". [PDF]
Afzali A, Van Rampelbergh R.
europepmc +1 more source
A Tri-Band Omnidirectional Shark-Fin Antenna for Vehicle Applications: Design and Analysis. [PDF]
Han CZ +6 more
europepmc +1 more source
Enhanced output of Fe<sup>2+</sup>/Fe<sup>3+</sup> liquid energy conversion using a methanol-acetone mixed solvent. [PDF]
Miyama R, Abe Y, Abe H, Inoue D.
europepmc +1 more source
??? ???????????? ?????? ??? ????????? ?????? ???????????? ?????? ????????? ???????????? ?????? ???????????? ?????? ?????????(NFV; Network Functions Virtualization) ????????? LTE(Long Term Evolution) ?????? ?????? ???????????? ????????? ?????? ????????????
?????????
core
Protective effect of <i>Loranthus tanakae</i> Franch. & Sav. on allergic asthma induced by ovalbumin. [PDF]
Park SH +10 more
europepmc +1 more source

